Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...

JCR today announced that it achieved the enrollment of the target number of participants in the global Phase III clinical trial of JR-141.

Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But ...

This outperformance is indicative of investor confidence in the pharmaceutical giant's ambitious transformation strategy as ...

Researchers from the National University of Singapore (NUS) have solved a 60-year-old mystery in bacterial cell envelope ...

For patients with multiple myeloma, the use of novel agents in first-line triplet and quadruplet induction regimens -- with ...

AbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells.

With an FDA IND clearance, the firm will test IKS014 as an alternative for HER2-positive solid tumor patients in the US who have relapsed on other therapies.

The majority of children do not need a tonsillectomy.” But when done for the right reasons, tonsillectomy offers a meaningful ...

Birgitte Stephensen, Executive Vice President and Chief Legal Officer to retire after 23 years with Genmab A/S Greg Mueller joins as new Executive Vice President, General Counsel and Chief Legal ...

Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...